Loading...
ROCO
4431
Market cap25mUSD
Oct 08, Last price  
22.35TWD
1D
9.29%
1Q
29.94%
Jan 2017
19.45%
IPO
78.51%
Name

Mytrex Health Technologies Inc

Chart & performance

D1W1MN
ROCO:4431 chart
P/E
—
P/S
0.42
EPS
—
Div yield, %
—
Shrs. gr., 5y
2.32%
Rev. gr., 5y
13.70%
Revenues
1.94b
+10.59%
398,421,0001,023,640,000291,623,0001,471,549,0001,292,969,0001,758,684,0001,944,844,000
Net income
-17m
L-79.85%
9,318,000352,274,000-14,011,000-91,901,000-56,219,000-82,375,000-16,600,000
CFO
201m
+534.79%
59,912,000440,760,00013,286,00072,478,000-4,255,00031,630,000200,783,000
Dividend
Sep 14, 20217.5 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1990 and headquartered in Taoyuan, Taiwan, Mytrex Health Technologies, Inc. operates globally across Taiwan, Asia, Europe, and other international markets, specializing in the production and distribution of diverse non-woven fabrics. The company's offerings include advanced electrostatic filtration materials utilized in medical and industrial masks, as well as for various other filtration purposes. Additionally, Mytrex provides composite nonwoven products suitable for coolant and air filters, vacuum filter bags, HEPA and cabin filters, and water filtration compounds. Its portfolio also features thermal insulation materials for applications such as gloves, socks, shoes, hats, clothing, and mask insulation. Beyond manufacturing, Mytrex offers comprehensive services to hospitals, encompassing linen laundry and leasing, logistics support, and medical supply provisions. The company further extends its business to the sale of pharmaceuticals and medical hygiene items, alongside managing medical clothing products.

Key people

Xingyan Li
Deputy General Manager, Head of Finance & Accounting · since 2025
Yicheng Wu
Deputy General Manager · since 2020
Zhaoyuan Zeng
Deputy General Manager · since 1994
Director · since 2020
Chairman of the Board · since 2024
Wenren Yang
Director · since 2024
Changrong Zhang
Director · since 2017
Independent Director · since 2018
Hengyu Zhang
Independent Director · since 2019
IPO date
Aug 30, 2011
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT